Home > Balance Sheet > NATCO PHARMA

NATCO PHARMA
Total Non-Current Liabilities

    Back to Balance Sheet
NATCO PHARMA is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
Top Undervalued Small Cap Stocks
AD     Remove this Ad

NATCO PHARMA Last 5 Year Total Non-Current Liabilities History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
Total Non-Current Liabilities ₹25 Cr₹61 Cr₹101 Cr₹135 Cr₹143 Cr

What is the latest Total Non-Current Liabilities ratio of NATCO PHARMA ?

The latest Total Non-Current Liabilities ratio of NATCO PHARMA is ₹25 Cr based on Mar2025 Consolidated results.
Year Total Non-Current Liabilities
Mar2025₹25 Cr
Mar2024₹61 Cr
Mar2023₹101 Cr
Mar2022₹135 Cr
Mar2021₹143 Cr

How is Total Non-Current Liabilities of NATCO PHARMA Trending?

Years Total Non-Current Liabilities % Change
Mar2025 ₹25 Cr
-59.18
Mar2024 ₹61 Cr
-39.30
Mar2023 ₹101 Cr
-25.61
Mar2022 ₹135 Cr
-5.46
Mar2021 ₹143 Cr -

Compare Total Non-Current Liabilities of peers of NATCO PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
NATCO PHARMA ₹15,954.2 Cr 0.9% 6.8% 0.6% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹413,753.0 Cr 1.5% 5.5% 0.5% Stock Analytics
DIVIS LABORATORIES ₹167,032.0 Cr 2.3% 3.6% 7.8% Stock Analytics
TORRENT PHARMACEUTICALS ₹143,426.0 Cr -0.5% 5.3% 40.2% Stock Analytics
CIPLA ₹108,360.0 Cr -1.1% -2.2% -8.9% Stock Analytics
DR REDDYS LABORATORIES ₹106,859.0 Cr 0.9% 5.2% 7% Stock Analytics


NATCO PHARMA Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
NATCO PHARMA

0.9%

6.8%

0.6%

SENSEX

0.2%

1.1%

8.8%


You may also like the below Video Courses